Literature DB >> 16243391

Design of modular non-viral gene therapy vectors.

Laura De Laporte1, Jennifer Cruz Rea, Lonnie D Shea.   

Abstract

Gene delivery has numerous potential applications both clinically and for basic science research. Non-viral vectors represent the long-term future of gene therapy and biomaterials are a critical component for the development of efficient delivery systems. Biomaterial development combined with fundamental studies of virus function and cellular processes will enable the molecular level design of modular vectors. Vectors are being developed based on cationic polymers or lipids that contain functional groups to mediate appropriate interactions with the extracellular environment or to interface with specific cellular processes. This review describes recent progress on the development of biomaterials for non-viral vectors and highlights opportunities for future development. Ultimately, efficient vectors will expand the traditional applications of gene therapy within the clinic and may enable numerous other opportunities within diagnostics, biotechnology, and basic science research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16243391      PMCID: PMC2648393          DOI: 10.1016/j.biomaterials.2005.09.036

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  52 in total

1.  Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors.

Authors:  S Li; S P Wu; M Whitmore; E J Loeffert; L Wang; S C Watkins; B R Pitt; L Huang
Journal:  Am J Physiol       Date:  1999-05

2.  Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery.

Authors:  R Kircheis; A Kichler; G Wallner; M Kursa; M Ogris; T Felzmann; M Buchberger; E Wagner
Journal:  Gene Ther       Date:  1997-05       Impact factor: 5.250

3.  Multilayered thin films that sustain the release of functional DNA under physiological conditions.

Authors:  Jingtao Zhang; Lynn S Chua; David M Lynn
Journal:  Langmuir       Date:  2004-09-14       Impact factor: 3.882

4.  Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer.

Authors:  A Kichler; K Mechtler; J P Behr; E Wagner
Journal:  Bioconjug Chem       Date:  1997 Mar-Apr       Impact factor: 4.774

5.  DNA-polycation nanospheres as non-viral gene delivery vehicles.

Authors:  K W Leong; H Q Mao; V L Truong-Le; K Roy; S M Walsh; J T August
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

6.  Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers.

Authors:  T B Wyman; F Nicol; O Zelphati; P V Scaria; C Plank; F C Szoka
Journal:  Biochemistry       Date:  1997-03-11       Impact factor: 3.162

7.  PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.

Authors:  M Ogris; S Brunner; S Schüller; R Kircheis; E Wagner
Journal:  Gene Ther       Date:  1999-04       Impact factor: 5.250

8.  DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach.

Authors:  Tatiana Segura; Peter H Chung; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

9.  Lysosome-disrupting peptide increases the efficiency of in-vivo gene transfer by liposome-encapsulated DNA.

Authors:  M Baru; O Nahum; H Jaaro; J Sha'anani; I Nur
Journal:  J Drug Target       Date:  1998       Impact factor: 5.121

10.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Authors:  O Boussif; F Lezoualc'h; M A Zanta; M D Mergny; D Scherman; B Demeneix; J P Behr
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  29 in total

Review 1.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

Review 2.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

3.  Nanomedicine for gene therapy.

Authors:  Susan Muthe Alex; Chandra P Sharma
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

4.  Optimization of PAMAM-gold nanoparticle conjugation for gene therapy.

Authors:  Elizabeth R Figueroa; Adam Y Lin; Jiaxi Yan; Laureen Luo; Aaron E Foster; Rebekah A Drezek
Journal:  Biomaterials       Date:  2013-11-26       Impact factor: 12.479

5.  Fibrin hydrogels for non-viral vector delivery in vitro.

Authors:  Anne des Rieux; Ariella Shikanov; Lonnie D Shea
Journal:  J Control Release       Date:  2009-02-20       Impact factor: 9.776

6.  Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.

Authors:  Laura De Laporte; Anna Lei Yan; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-01-13       Impact factor: 12.479

7.  New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery.

Authors:  Jian-Ming Lü; Zhengdong Liang; Xiaoxiao Wang; Jianhua Gu; Qizhi Yao; Changyi Chen
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

8.  Layered PLG scaffolds for in vivo plasmid delivery.

Authors:  Christopher B Rives; Anne des Rieux; Marina Zelivyanskaya; Stuart R Stock; William L Lowe; Lonnie D Shea
Journal:  Biomaterials       Date:  2008-10-17       Impact factor: 12.479

9.  The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation.

Authors:  Mahdi Karimi; Pinar Avci; Rezvan Mobasseri; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopart Res       Date:  2013-04-01       Impact factor: 2.253

Review 10.  Nanoparticulate systems for polynucleotide delivery.

Authors:  Ashwin Basarkar; Jagdish Singh
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.